Rakovina Therapeutics Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Rakovina Therapeutics's estimated annual revenue is currently $603k per year.(i)
  • Rakovina Therapeutics's estimated revenue per employee is $100,500

Employee Data

  • Rakovina Therapeutics has 6 Employees.(i)
  • Rakovina Therapeutics grew their employee count by -14% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$33.4M166-10%N/AN/A
#2
$68.8M27418%$942.6MN/A
#3
$23.5M1170%N/AN/A
#4
$1.6M1645%$3.7MN/A
#5
$0.7M70%N/AN/A
#6
$1.5M1515%N/AN/A
#7
$1.4M1417%N/AN/A
#8
$0.7M7-12%N/AN/A
#9
$17.7M8824%N/AN/A
#10
$4.6M23-56%N/AN/A
Add Company

What Is Rakovina Therapeutics?

Rakovina Therapeutics’ focus is the development of new cancer treatments based on novel DNA-damage response technologies. The Company has established a pipeline of novel DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials and obtaining marketing approval for new cancer therapeutics from Health Canada, the United States Food and Drug Administration and similar international regulatory agencies.

keywords:N/A

N/A

Total Funding

6

Number of Employees

$603k

Revenue (est)

-14%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M6N/AN/A
#2
$0.4M6N/AN/A
#3
$0.4M6N/AN/A
#4
$0.4M6N/AN/A
#5
$0.6M6N/AN/A